A detailed history of Venture Visionary Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Venture Visionary Partners LLC holds 686 shares of VRTX stock, worth $309,365. This represents 0.01% of its overall portfolio holdings.

Number of Shares
686
Previous 687 0.15%
Holding current value
$309,365
Previous $322,000 0.93%
% of portfolio
0.01%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$460.0 - $505.78 $460 - $505
-1 Reduced 0.15%
686 $319,000
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $5,499 - $6,797
14 Added 2.08%
687 $322,000
Q1 2024

May 13, 2024

SELL
$407.69 - $446.08 $3,669 - $4,014
-9 Reduced 1.32%
673 $281,000
Q4 2023

Feb 15, 2024

BUY
$343.0 - $410.68 $4,802 - $5,749
14 Added 2.1%
682 $277,000
Q4 2023

Jan 24, 2024

SELL
$343.0 - $410.68 $1,372 - $1,642
-4 Reduced 0.6%
668 $271,000
Q3 2023

Oct 13, 2023

SELL
$338.18 - $362.46 $1,352 - $1,449
-4 Reduced 0.59%
672 $233,000
Q2 2023

Jul 14, 2023

SELL
$314.42 - $351.91 $1,572 - $1,759
-5 Reduced 0.73%
676 $237,000
Q1 2023

Apr 13, 2023

BUY
$283.23 - $323.1 $192,879 - $220,031
681 New
681 $214,000
Q2 2022

Jul 26, 2022

BUY
$234.96 - $292.55 $79,651 - $99,174
339 New
339 $95,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Venture Visionary Partners LLC Portfolio

Follow Venture Visionary Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Venture Visionary Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Venture Visionary Partners LLC with notifications on news.